Kinnevik AB (publ)

Concentrated strategyLong-term holder

Total reported value

$65.6M

Reporting period: 2025-09-30 · Number of holdings: 1

KINNEVIK AB (PUBL) disclosed 1 holdings in its latest 13F filing for the period ending 2025-09-30, with total reported value of $65.6M and a quarterly turnover rate of 8.3%.

Browse other institutions with under $100M AUM Browse other institutions starting with "K"

Personality snowflake

Concentration: 100
Portfolio Stability: 8.25
Momentum/Contrarian: 50
Sector conviction: 0
Diversification: 2
Sizing Uniformity: —

Recent moves

Unchanged RXRX
0.0%　-$5.5M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change	4Q Trend
1	RXRX	Recursion Pharmaceuticals-a	Stock-Healthcare	100.00%	—	—

Reported value over time

Sector allocation

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2025-09-30	1	$65.6M	8	1RXRX Top holdings2025-09-30 1.RXRX
2025-06-30	1	$68.0M	0	1RXRX Top holdings2025-06-30 1.RXRX
2025-03-31	1	$71.1M	0	1RXRX Top holdings2025-03-31 1.RXRX
2024-12-31	1	$80.5M	0	1RXRX Top holdings2024-12-31 1.RXRX
2024-09-30	1	$78.5M	0	1RXRX Top holdings2024-09-30 1.RXRX
2024-06-30	1	$89.3M	0	1RXRX Top holdings2024-06-30 1.RXRX
2024-03-31	1	$103.7M	0	1RXRX Top holdings2024-03-31 1.RXRX
2023-12-31	1	$102.6M	0	1RXRX Top holdings2023-12-31 1.RXRX
2023-09-30	1	$79.6M	0	1RXRX Top holdings2023-09-30 1.RXRX
2023-06-30	1	$77.7M	0	1RXRX Top holdings2023-06-30 1.RXRX
2023-03-31	2	$74.5M	0	1RXRX2G07031 Top holdings2023-03-31 1.RXRX 2.G07031
2022-12-31	3	$177.3M	0	1TDOC 2RXRX3G07031 Top holdings2022-12-31 1.TDOC 2.RXRX 3.G07031
2022-09-30	2	$119.3M	0	1TDOC2G07031 Top holdings2022-09-30 1.TDOC 2.G07031
2022-06-30	2	$176.1M	0	1TDOC2G07031 Top holdings2022-06-30 1.TDOC 2.G07031
2022-03-31	2	$479.4M	0	1TDOC2G07031 Top holdings2022-03-31 1.TDOC 2.G07031
2021-12-31	2	$778.6M	0	1TDOC2G07031 Top holdings2021-12-31 1.TDOC 2.G07031

Holding changes this quarter

Position changes disclosed by Kinnevik AB (publ) for the quarter ending 2025-09-30, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	RXRX	Recursion Pharmaceuticals-a	—	—	Unchanged

FAQ

What is Kinnevik AB (publ) and what type of investor is it?

Kinnevik AB (publ) is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2025-09-30), the firm manages a tracked equity portfolio valued at approximately $65.6M, spread across 1 disclosed positions.

What are Kinnevik AB (publ)'s largest equity positions?

Based on the latest 13F filing, Kinnevik AB (publ)'s top holdings by market value are: 1. Recursion Pharmaceuticals-a (RXRX) — $65.6M (100.0%)

What changes did Kinnevik AB (publ) make in its most recent portfolio filing?

No notable portfolio changes were recorded for Kinnevik AB (publ) in the most recent quarter. Holdings appear to have remained relatively stable.

What sectors does Kinnevik AB (publ) focus on?

Kinnevik AB (publ) is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 100.0%